NovoCure Ltd (NAS:NVCR)
$ 23.15 0.84 (3.77%) Market Cap: 2.49 Bil Enterprise Value: 2.22 Bil PE Ratio: 0 PB Ratio: 6.93 GF Score: 60/100

Q4 2020 Novocure Ltd Earnings Call Transcript

Feb 25, 2021 / 01:00PM GMT
Release Date Price: $148.9 (-14.00%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the NovoCure Fourth Quarter and Full Year 2020 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Gabrielle Fernandes, Director of Investor Relations. Thank you. Please go ahead, ma'am.

Gabrielle Fernandes

Good morning, everyone, and thank you for joining us to review NovoCure's fourth quarter and full year 2020 performance. I am joined on the phone by our Executive Chairman, Bill Doyle; our CEO, Asaf Danziger; and our CFO, Ashley Cordova. Other members of our executive leadership team are also on the call and available for Q&A.

The slides presented today can be viewed on our website, www.novocure.com, by clicking on the link for fourth quarter and full year 2020 financial results located in the Events section of our Investor Relations page.

Before we start, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot